Cargando…

Trait Anxiety as a Risk Factor for Impulse Control Disorders in de novo Parkinson’s Disease

BACKGROUND: In addition to the well-known motor symptoms, patients with Parkinson’s disease (PD) also frequently experience disabling non-motor symptoms including impulse control disorders (ICDs). ICDs are characterized by a loss of voluntary control over impulses, drives, or temptations regarding e...

Descripción completa

Detalles Bibliográficos
Autores principales: Waskowiak, Pauline, Koppelmans, Vincent, Ruitenberg, Marit F.L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925112/
https://www.ncbi.nlm.nih.gov/pubmed/34897102
http://dx.doi.org/10.3233/JPD-212959
_version_ 1784669999766437888
author Waskowiak, Pauline
Koppelmans, Vincent
Ruitenberg, Marit F.L.
author_facet Waskowiak, Pauline
Koppelmans, Vincent
Ruitenberg, Marit F.L.
author_sort Waskowiak, Pauline
collection PubMed
description BACKGROUND: In addition to the well-known motor symptoms, patients with Parkinson’s disease (PD) also frequently experience disabling non-motor symptoms including impulse control disorders (ICDs). ICDs are characterized by a loss of voluntary control over impulses, drives, or temptations regarding excessive hedonic behavior. OBJECTIVE: The present study examined whether depression and anxiety in de novo PD patients predict the prospective development of ICDs. METHODS: We selected 330 de novo PD patients from the Parkinson’s Progression Markers Initiative database who were free of ICDs at the start of the study. ICD presence at baseline and follow-up assessments was evaluated via the shortened version of the Questionnaire for Impulsive-Compulsive Disorders (QUIP-S). Baseline depression and anxiety were measured via the Geriatric Depression Scale (GDS-15) and State-Trait-Anxiety Inventory (STAI-Y), respectively. RESULTS: A total of 149 participants (45.2%) developed an ICD at follow-up and average time of ICD onset was 35 months after baseline. Results of a Cox regression analysis showed that STAI-Y scores but not GDS-15 scores significantly predicted ICD presence. Specifically, scores reflecting higher trait anxiety were associated with an increased risk of developing an ICD. This effect was not confounded by age, gender or UPDRS motor score. We also replicated the well-established result that dopamine agonist use is predictive of ICDs. CONCLUSION: Our findings indicate that higher anxiety levels in de novo PD patients represent a risk factor for ICD development during the course of the disorder. This highlights the need for early and routine based anxiety screening in these patients.
format Online
Article
Text
id pubmed-8925112
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher IOS Press
record_format MEDLINE/PubMed
spelling pubmed-89251122022-03-30 Trait Anxiety as a Risk Factor for Impulse Control Disorders in de novo Parkinson’s Disease Waskowiak, Pauline Koppelmans, Vincent Ruitenberg, Marit F.L. J Parkinsons Dis Research Report BACKGROUND: In addition to the well-known motor symptoms, patients with Parkinson’s disease (PD) also frequently experience disabling non-motor symptoms including impulse control disorders (ICDs). ICDs are characterized by a loss of voluntary control over impulses, drives, or temptations regarding excessive hedonic behavior. OBJECTIVE: The present study examined whether depression and anxiety in de novo PD patients predict the prospective development of ICDs. METHODS: We selected 330 de novo PD patients from the Parkinson’s Progression Markers Initiative database who were free of ICDs at the start of the study. ICD presence at baseline and follow-up assessments was evaluated via the shortened version of the Questionnaire for Impulsive-Compulsive Disorders (QUIP-S). Baseline depression and anxiety were measured via the Geriatric Depression Scale (GDS-15) and State-Trait-Anxiety Inventory (STAI-Y), respectively. RESULTS: A total of 149 participants (45.2%) developed an ICD at follow-up and average time of ICD onset was 35 months after baseline. Results of a Cox regression analysis showed that STAI-Y scores but not GDS-15 scores significantly predicted ICD presence. Specifically, scores reflecting higher trait anxiety were associated with an increased risk of developing an ICD. This effect was not confounded by age, gender or UPDRS motor score. We also replicated the well-established result that dopamine agonist use is predictive of ICDs. CONCLUSION: Our findings indicate that higher anxiety levels in de novo PD patients represent a risk factor for ICD development during the course of the disorder. This highlights the need for early and routine based anxiety screening in these patients. IOS Press 2022-02-15 /pmc/articles/PMC8925112/ /pubmed/34897102 http://dx.doi.org/10.3233/JPD-212959 Text en © 2022 – The authors. Published by IOS Press https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) License (https://creativecommons.org/licenses/by-nc/4.0/) , which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Report
Waskowiak, Pauline
Koppelmans, Vincent
Ruitenberg, Marit F.L.
Trait Anxiety as a Risk Factor for Impulse Control Disorders in de novo Parkinson’s Disease
title Trait Anxiety as a Risk Factor for Impulse Control Disorders in de novo Parkinson’s Disease
title_full Trait Anxiety as a Risk Factor for Impulse Control Disorders in de novo Parkinson’s Disease
title_fullStr Trait Anxiety as a Risk Factor for Impulse Control Disorders in de novo Parkinson’s Disease
title_full_unstemmed Trait Anxiety as a Risk Factor for Impulse Control Disorders in de novo Parkinson’s Disease
title_short Trait Anxiety as a Risk Factor for Impulse Control Disorders in de novo Parkinson’s Disease
title_sort trait anxiety as a risk factor for impulse control disorders in de novo parkinson’s disease
topic Research Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925112/
https://www.ncbi.nlm.nih.gov/pubmed/34897102
http://dx.doi.org/10.3233/JPD-212959
work_keys_str_mv AT waskowiakpauline traitanxietyasariskfactorforimpulsecontroldisordersindenovoparkinsonsdisease
AT koppelmansvincent traitanxietyasariskfactorforimpulsecontroldisordersindenovoparkinsonsdisease
AT ruitenbergmaritfl traitanxietyasariskfactorforimpulsecontroldisordersindenovoparkinsonsdisease